Litcius/Paper detail

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

David Ishola, Daniela Manno, Muhammed O. Afolabi, Babajide Keshinro, Viki Bockstal, Baimba Rogers, Kwabena Owusu-Kyei, Alimamy Serry-Bangura, Ibrahim Swaray, Brett Lowe, Dickens Kowuor, Frank Baiden, Thomas A. Mooney, Elizabeth Smout, Brian Köhn, Godfrey T Otieno, Morrison Jusu, Julie Foster, Mohamed Samai, Gibrilla F. Deen, Heidi J. Larson, Shelley Lees, Neil Goldstein, Katherine E. Gallagher, Auguste Gaddah, Dirk Heerwegh, Benoît Callendret, Kerstin Lühn, Cynthia Robinson, Maarten Leyssen, Brian Greenwood, Macaya Douoguih, Bailah Leigh, Deborah Watson‐Jones, M Kargbo, E Bockarie, N L James, A Kabbah, A Kamara, Kellie Koroma, S O Langley, Naoma William, R Kessebeh, Thomas A. Mooney, Lansana Conteh, Elizabeth Smout, K Allieu, K Bangura, Mohamed Bangura, M A Bangura, H Jalloh, Abdulai Jalloh, I Kamara, M Kamara, Alimamy Saidu Konteh, S Koroma, C Marrah, Mohamed Sesay, Mohamed Sesay, A T Deen, Abdulai Tejan Jalloh, R M Kaimbay, David Kain, A Kamara, E L Kamara, M Kamara, Osman Kamara, I Kamara, Senesie Kamara, M Kanneh, Alusine H. Koroma, D Lahai, I S Mansaray, W S Marah, Massah Massaquoi, A Nabie, N S Saidu, I Samai, J N Tengheh, Abdulai Turay, A Fornah, Fatmata Sesay, A Sow, E Swaray, F Mansaray, T Ade-Cole, Lamin Molecule Bangura, M L Conteh, A Kabbah, Adama Koroma, Mohamed Koroma, Amy Sam, T Scott, T Sessie, J-H C Sunders, Samuel Turay, J Weekes, Mahmud Sheku, Laura Gibson, Dickens Kowuor

2021The Lancet Infectious Diseases95 citationsDOIOpen Access PDF

Topics & Concepts

Ebola vaccineSierra leoneEbola virusMedicineVirologyRegimenEbola Hemorrhagic FeverVaccinationVirusInternal medicineDevelopment economicsEconomicsViral Infections and Outbreaks ResearchBacillus and Francisella bacterial researchSARS-CoV-2 and COVID-19 Research
Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial | Litcius